Shadia Jalal

  • 1592 Citations
  • 17 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Shadia Jalal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Caregivers Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carboplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2009 2019

  • 1592 Citations
  • 17 h-Index
  • 47 Article
  • 5 Conference contribution
  • 3 Review article
  • 1 Chapter
Acceptance and Commitment Therapy
Lung Neoplasms

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

Sharman, J. P., Wheler, J. J., Einhorn, L., Dowlati, A., Shapiro, G. I., Hilton, J., Burke, J. M., Siddiqi, T., Whiting, N. & Jalal, S. I., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

Open Access
Testicular Neoplasms
2 Citations (Scopus)

Doppler fluctuation spectroscopy of intracellular dynamics in living tissue

Li, Z., Sun, H., Turek, J., Jalal, S., Childress, M. & Nolte, D. D., Apr 1 2019, In : Journal of the Optical Society of America A: Optics and Image Science, and Vision. 36, 4, p. 665-677 13 p.

Research output: Contribution to journalArticle

Light scattering
light scattering

Doppler imaging of intracellular dynamics in clinical cancer chemotherapy

Nolte, D. D., Turek, J. J., Matei, D. E. & Jalal, S., Jan 1 2019, Clinical and Preclinical Optical Diagnostics II. Brown, J. Q. & van Leeuwen, T. G. (eds.). SPIE, 110730J. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; vol. 11073).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Breast Neoplasms
5 Citations (Scopus)

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

Bang, Y. J., Kang, Y. K., Catenacci, D. V., Muro, K., Fuchs, C. S., Geva, R., Hara, H., Golan, T., Garrido, M., Jalal, S., Borg, C., Doi, T., Yoon, H. H., Savage, M. J., Wang, J., Dalal, R. P., Shah, S., Wainberg, Z. A. & Chung, H. C., Jan 1 2019, In : Gastric Cancer.

Research output: Contribution to journalArticle

Open Access
Esophagogastric Junction
Combination Drug Therapy